Engineering cytokines for cancer immunotherapy: a systematic review.

Fu, Yong; Tang, Renhong; Zhao, Xiaofeng

Fu, Yong; Tang, Renhong; Zhao, Xiaofeng.

Affiliation

Fu Y; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co., Ltd., Nanjing, China.
Tang R; Jiangsu Simcere Pharmaceutical Co, Ltd., Nanjing, China.
Zhao X; State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co., Ltd., Nanjing, China.

Front Immunol ; 14: 1218082, 2023.

Article in En | MEDLINE | ID: mdl-37483629

Subject(s)

Cytokines; Neoplasms; Humans; Cytokines/therapeutic use; Neoplasms/therapy; Immunotherapy/methods; Tumor Microenvironment

Key words

cancer immunotherapy; engineering cytokine; fusion protein; immunocytokine; polyethylene glycol; prodrug cytokine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cytokines / Neoplasms Type of study: Systematic_reviews Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google